Publications from the National Academies of Sciences, Engineering, and Medicine provide objective and straightforward advice to decision makers and the public. This site includes Health and Medicine Division (HMD) publications released after 1998. A complete list of HMD’s publications from its establishment in 1970 to the present is available as a PDF.
The National Cancer Policy Summit: Opportunities and ...
Released: February 28, 2011
Technological advances are altering the way cancer research is conducted and cancer care is delivered, and research increasingly is an international effort. At the same time, research budgets are shrinking and the cost of care is growing. The National Cancer Policy Summit brought together leaders in the cancer community to discuss these changes in research and care. Participants suggested many potential actions to provide more patient-centered cancer care, foster more collaboration, and achieve other goals to improve research and care.
Nanotechnology and Oncology – Workshop Summary : Health ...
Released: February 25, 2011
One way scientists are working to overcome challenges in cancer treatment and improve cancer care is through nanotechnology. The National Cancer Policy Forum held a workshop July 12-13, 2010, to explore challenges in the use of nanotechnology in oncology.
Extending the Spectrum of Precompetitive Collaboration in ...
Released: July 22, 2010
The IOM’s National Cancer Policy Forum held a workshop February 9-10, 2010, to explore the growing importance of precompetitive collaboration in oncology drug development. Speakers discussed the advantages and challenges of collaborating with competitors to achieve goals with the potential to benefit everyone, and offered lessons learned and best practices to facilitate future precompetitive collaboration.
Evaluation of Biomarkers and Surrogate Endpoints in Chronic ...
Released: May 12, 2010
Many people naturally assume that the claims made for foods and nutritional supplements have the same degree of scientific grounding as those for medication, but that is not always the case. The IOM recommends that the FDA adopt a consistent scientific framework for biomarker evaluation in order to achieve a rigorous and transparent process.
A National Cancer Clinical Trials System for the 21st Century ...
Released: April 15, 2010
The National Cancer Institute’s (NCI) Clinical Tri¬als Cooperative Group Program has played a key role in developing new and improved cancer therapies. However, the program is falling short of its potential, and the IOM recommends changes that aim to transform the Cooperative Group Program into a dynamic system that efficiently responds to emerging scientific knowledge; involves broad cooperation of stakeholders; and leverages evolving technologies to provide high-quality, practice-changing research.
Future Directions for the National Healthcare Quality and ...
Released: April 14, 2010
The Agency for Healthcare Research and Quality’s annual National Healthcare Quality Report (NHQR) and the National Healthcare Disparities Report (NHDR) reveal areas in which health care performance has improved over time and identify major shortcomings. The IOM concludes that the next generation of reports can be improved in ways that would make them more influential in promoting change in the health care system.
Regionalizing Emergency Care. Workshop Summary : Health ...
Released: March 22, 2010
During medical emergencies, hospital staff and emergency medical services providers, can face barriers in delivering the fastest and best possible care. In 2006, the IOM recommended that the federal government implement a regionalized emergency care system to improve cooperation and overcome these challenges. Three years later, the IOM held a workshop to assess the nation’s progress toward regionalizing emergency care.
Policy Issues in the Development of Personalized Medicine in ...
Released: February 08, 2010
As cancer care becomes more personalized, patients will receive preventive or therapeutic interventions based on their susceptibilities or predicted responses. But before the use of personalized cancer care can reach its full potential, the health care system must resolve a number of policy issues. To explore these policy challenges, the National Cancer Policy Forum held this workshop in June 2009.
Redesigning Continuing Education in the Health Professions ...
Released: December 04, 2009
Today’s professional health workforce is not consistently prepared to provide high quality health care and assure patient safety. Redesigning Continuing Education in the Health Professions examines continuing education for all health professionals, explores development of a national continuing education institute, and offers guidance on the establishment and operation of an institute to develop a coordinated continuing professional development system.